Source: International Congress 2016 – Prognostic variables in lung cancer I
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Giovanni Ferrara (Stockholm, Sweden), Elsa Davisdsson, Nicola Murgia, Cristian Ortiz-Villalon, Emil Wiklundh, Magnus Sköld, Karl Kölbeck, Giovanni Ferrara. Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma. Eur Respir J 2016; 48: Suppl. 60, 2859

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of molecular changes in resected pulmonary adenocarcinomas Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The diagnosis of malignancy following a venous thromboembolic event - how high is the risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Clinical characteristics of 32 patients with BRAF V600E-mutated lung adenocarcinoma Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor? Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Relationship between risk factors for lung cancer and tumor size Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 A functional polymorphism in XRCC1 gene is associated with lung cancer risk in a Korean population Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Comparative analysis of the results of surgical treatment for pulmonary metastases from colorectal cancer and metastases from other primary origin Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Accelerated lung function decline increases the risk of lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Network-based approach identifies SP1 as a common node in emphysema and lung cancer Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Lung adenocarcinoma with concomitant EGFR mutation and ALK rearrangement: Analysis of two cases and literature review Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Clinicopathological prognostic factors in operated for pulmonary carcinoid tumor patients Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014